Latest News

Uniseed announces second investment from new fund – MetabloQ

MEDIA RELEASE   New drugs in development to starve cancer cells Revolutionary new cancer therapies for patients suffering with some of the most difficult-to-treat cancers are now being developed following a major discovery by scientists in the ACRF Centenary Cancer...

Uniseed makes new investment into drug development company Exonate Ltd

  Uniseed makes £200,000 investment in Exonate as part of £1.5 million round from existing and new investors Exonate awarded £4.9 million from the Wellcome Trust ‐ Seeding Drug Discovery Initiative Program to develop eye drop treatment for wet age‐related macular...

Exonate receives Wellcome Trust funding

Exonate receives Wellcome Trust funding to develop eye drop treatment for wet age-related macular degeneration (wet AMD)   Early stage biotechnology company targeting ophthalmology and other areas of unmet medical need Cambridge, UK. Monday 6th February 2017 –...

Uniseed co – leads investment round in probiotics drink PERKii

Uniseed makes $1M investment in PERKii from its third and largest fund supported by four Group of 8 Universities and CSIRO. An additional $950K brought in from Uniseed’s network of sophisticated investors, with Uniseed managing these funds on their behalf. PERKii...

Uniseed launches $50 million fund with new investment partners

Uniseed now operating at four of the Group of 8 Universities and CSIRO Early stage investment in all technology sectors Uniseed, a venture fund operating at the Universities of Melbourne, New South Wales and Queensland, is pleased to announce that the University of...

MEDIA ENQUIRIES
Interested in our investees?
Contact us.